San Diego, Sept. 19, 2011 (Shareholders Foundation) -- An investigation on behalf of investors in shares of Bovie Medical Corporation (AMEX:BVX) over possible Violations of Federal Securities Laws was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Bovie Medical Corporation (Public, AMEX:BVX) concerning allegations that officials at the Bovie Medical Corp. caused Bovie Medical to take actions which resulted in at least three major lawsuits, including one for patent infringement, which caused the company to lose its rights to manufacture its SEER and BOSS technologies. As a result, so the investigation, Bovie Medical's ability to produce many of its medical products has been threatened, and it has been unable to capitalize on material corporate and market opportunities. Additionally, investigation by a law firm also concerns allegations that members of the Board, including Bovie Medicals Chief Operating Officer possibly engaged in self-dealing practices that routinely awarded senior management positions to unqualified friends and family members.

Bovie Medicals annual Revenue fell from $28.78million in 07, respectively $28.10million for 2008, to $26.954million in 2009 and $24.23million in 2010. Its Net Income fell over the same time frame from $3.80million in 07 to a Net Loss of $1.53million in 2010.

Shares of Bovie Medical Corporation (Public, AMEX:BVX) dropped from as high as $9.69 during 2009 to as low as $1.84 in October 2010 and traded recently at roughly $2.80 per share.